JTBR
BBNX icon

James T. Borello RIA’s Beta Bionics BBNX Stock Holding History

James T. Borello RIA’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6
Closed -$183 – 1258
2025
Q4 		$183 Buy
+6
New +$160 ﹤0.01% 1027

Other funds holding BBNX

Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vestal Point Capital
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

James T. Borello RIA's BBNX Position: Q1 2026 in Review

James T. Borello RIA sold out of Beta Bionics (BBNX) in Q1 2026, closing a stake of 6 shares — an estimated $183 sold.

James T. Borello RIA first reported a position in BBNX in Q4 2025 and held it in 1 quarter. The position peaked at $183 in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • James T. Borello RIA reported no remaining Beta Bionics position as of Q1 2026 after selling out during the quarter.
  • James T. Borello RIA sold 6 Beta Bionics shares in Q1 2026, an estimated $183.
  • James T. Borello RIA first reported a position in Beta Bionics in Q4 2025 and held it in 1 quarter.
  • James T. Borello RIA's Beta Bionics position peaked at $183 in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on James T. Borello RIA's 13F filing for Q1 2026, filed 16 Oct 2026.